biomedicina slovenica


"APOMORPHINE" : 36

  1. Martinez-Martin Pablo; Reddy Prashanth; Katzenschlager Regina; Antonini Angelo; Todorova Antoniya; Odin Per; Henriksen Tove; Martin Anne; Calandrella Daniela; Rizos Alexandra; Gregorič Kramberger Milica; Pirtošek Zvezdan; Trošt Maja
    EuroInf
    2015
  2. Ribarič Samo
    The pharmacological properties and therapeutic use of apomorphine
    2012
  3. Pirtošek Zvezdan
    Myths and realities of continuous dopaminergic stimulation
    2011
  4. Georgiev Dejan; Danieli Aljoša; Ocepek Lidija; Novak Dominika; Zupančič-Križnar Nina; Trošt Maja; Pirtošek Zvezdan
    Othello syndrome in patients with Parkinson's disease
    2010
  5. Bartolič Andrej; Pirtošek Zvezdan; Rozman Janez; Ribarič Samo
    Tremor amplitude and tremor frequency variability in Parkinson's disease is dependent on activity and synchronisation of central oscillators in basal ganglia
    2009
  6. Glavan Gordana
    Intermittent l-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats
    2008
  7. Ribarič Samo; Rozman Janez
    Sensors for measurement of tremor type joint movements
    [Tipala za merjenje s tremorjem povzročenih gibov v sklepih]
    2007
  8. Pal Robert; Živin Marko; Milutinovič Aleksandra; Jernej Branimir; Glavan Gordana
    Effect of apomorphine on striatal synaptotagmin 7 mRNA levels in reserpinized rats
    2007
  9. Bartolić Andrej
    Razvoj metode za ambulantno merjenje tremorja pri bolnikih s Parkinsonovo boleznijo
    2005
  10. Glavan G; Živin M
    Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats
    2005
  11. Ocepek Lidija; Pirtošek Zvezdan
    Apomorphine in Parkinson's disease - the Ljubljana experience
    2005
  12. Bartolić A; Pirtošek Z; Rozman J; Ribarič S
    Postural stability of Parkinson's disease patients is improved by decreasing rigidity
    2005
  13. Banič Vladimir; Mark I; Ocepek L; Pirtošek Z
    Consistency of apomorphine - test results on parkinsonism
    2003
  14. Banić Vladimir; Mark Igor
    Kaj se zgodi s postsinaptičnimi receptorji pri parkinsonizmu?
    2003
  15. Flisar D; Pirtošek Z
    Case report: is apomorphine induced hypersexuality testosterone-related?
    1999
  16. Oblak Ciril
    Sodobno zdravljenje erektilne disfunkcije z zdravili
    2003
  17. Živin Marko; Šprah Lilijana; Sket Dušan
    Preizkus delovanja ergolinskega derivata Lek-9928 kot delnega agonista na dopaminskih receptorjih
    1994
  18. Bartolić Andrej
    Močnostni spekter nihanja med mirno stojo pri bolnikih s Parkinsonovo boleznijo
    2001
  19. Bartolić Andrej
    Močnostni spekter nihanja med mirno stojo pri bolnikih s Parkinsonovo boleznijo
    [Power spectrum of body oscillations during free stance in patients with Parkinson's disease]
    2001
  20. Pirtošek Zvezdan
    Agonistas dopaminergicos parciales: una alternativa de estrategia terapeutica
    1999
  21. Junginger HE; van der Geest R; Bodde HE; Danhol M
    Iontophoretic delivery of apomorphine - form in vitro modelling to the patient
    1999
  22. Suppan K; Homann CN; Wenzel K; Ivanic G; Ott E; Pirtošek Z
    The value of the foot tapping test in evaluating dopaminergic response in parkinsonian patients
    2000
  23. Flisar D; Pirtošek Z
    Apomorphine induced hypersexuality
    1999
  24. Šprah Lilijana
    Učinek spojine LEK-8829 na dopaminskih receptorjih pri podgani z enostransko okvaro striatuma
    1999
  25. Pirtošek Zvezdan; Merello Marcelo; Carlsson Arvid; Stern Gerald
    Preclamol and parkinsonian fluctuations
    1993
  26. Šprah Lilijana; Živin Marko; Sket Dušan
    Ergoline derivative LEK-8829-inducet turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine
    1999
  27. Šprah Lilijana
    Dopaminergična aktivnost ergolinskega derivata LEK-8829
    1997
  28. Pirtošek Z
    Medical treatment of Parkinson's disease
    [Medikamentno zdravljenje Parkinsonove bolezni]
    1996
  29. Ružička E; Roth J
    Apomorphine and cognitive function in Parkinson's disease
    [Apomorfin in kognitivna funkcija pri Parkinsonovi bolezni]
    1996
  30. Macedoni-Lukšič M; Sket D
    Scopolamine modulates the effects of continuous amphetamine in rats
    [Skopolamin modulira učinek kontinuirane aplikacije amfetamina pri podgani]
    1996
  31. Krisch I
    Vrednotenje antipsihotičnega potenciala dveh novosintetiziranih derivatov ergolina pri poskusnih živalih
    1995
  32. Merello M; Pirtošek Z; Bishop S; Lees AJ
    Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine
    1992
  33. Krisch I; Bole-Vunduk B; Lavrič B; Ocvirk A; Pepelnak M; Budihna MV; Sket D
    Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841
    1994
  34. Macedoni-Lukšič M
    Amfetaminski model psihoze pri podganah: modulacija dopaminskega sistema s holinergičnimi
    1993
  35. Miljković Lj; Sušić H; Ðorđević N
    Adrenaline induced arrhythmias: relation to transient ST segment deviation
    1987
  36. Kocjan D; Hodošček M; Hadži D
    Dopaminergic pharmacophore of ergoline and its analogues. A molecular electrostatic potential study
    1986



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics